logo
Rubio hails end of USAID as study says its elimination could contribute to 14 million deaths in next 5 years

Rubio hails end of USAID as study says its elimination could contribute to 14 million deaths in next 5 years

CNN4 days ago
US Secretary of State Marco Rubio hailed the end of the US Agency for International Development (USAID) Tuesday as a new analysis found that its demolition could contribute to 14 million deaths in the next five years.
'This era of government-sanctioned inefficiency has officially come to an end. Under the Trump Administration, we will finally have a foreign funding mission in America that prioritizes our national interests,' Rubio said in a post on Substack Tuesday.
'As of July 1st, USAID will officially cease to implement foreign assistance. Foreign assistance programs that align with administration policies—and which advance American interests — will be administered by the State Department, where they will be delivered with more accountability, strategy, and efficiency,' he said.
The rapid destruction of USAID, led by the Elon-Musk backed Department of Government Efficiency (DOGE), has seen thousands of foreign assistance programs slashed, including many focused on lifesaving work.
A study published Monday in The Lancet estimates that the USAID funding cuts could result in more than 14 million additional deaths by 2030. Nearly a third of those deaths – more than 4.5 million – are estimated to be among children younger than 5.
Authors of the study said that the effects of the funding cuts 'would be similar in scale to a global pandemic or a major armed conflict.'
'Unlike those events, however, this crisis would stem from a conscious and avoidable policy choice—one whose burden would fall disproportionately on children and younger populations, and whose consequences could reverberate for decades,' they wrote.
USAID funding was most likely to reduce mortality related to HIV/AIDS, followed by malaria, according to the Lancet study. Strong associations were also found with tropical diseases, diarrhoeal disease, nutritional deficiencies, lower respiratory infections, maternal mortality and tuberculosis.
A senior State Department official downplayed the Lancet's findings, saying Tuesday, 'a lot of these sort of studies are based on incorrect assumptions about what Secretary Rubio intends to and has done before.'
'I think he's been very clear that a lot of the life-saving work that we do will continue and will be made more efficient,' the official said.
However, aid groups have said that USAID's swift dismantlement, coupled with a sudden and sweeping freeze on foreign assistance in January, has already had devastating consequences.
The official was largely dismissive of criticism of the administration's moves.
'You can go back and relitigate all these little decisions. That's not our focus. That's not the secretary's focus. We are excited about what sort of the America first foreign assistance agenda is going to look like and how much impact we can have moving forward,' they said.
The official said the administration is looking at new metrics to gauge the success of US assistance work.
'We want to see sort of more bilateral engagement. We want to see more investment from our partners, co-investment. We want to see trade deals, compacts, agreements, to work together on stuff,' they said. 'Those are a big indicator of success for us.'
'What we want to do with this is build bridges bilaterally consistent with the president's sort of mission and diplomatic agenda more broadly,' they said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

De minimis exemption slated to end in 2027
De minimis exemption slated to end in 2027

Yahoo

time36 minutes ago

  • Yahoo

De minimis exemption slated to end in 2027

This story was originally published on Supply Chain Dive. To receive daily news and insights, subscribe to our free daily Supply Chain Dive newsletter. The de minimis exemption will be eliminated in two years after President Donald Trump signed a sweeping policy bill into law on Friday. As part of the package introduced as the 'One Big Beautiful Bill Act,' the U.S. will repeal the exemption allowing imports under $800 to enter the country duty and tax free, effective July 1, 2027. Exemptions will remain in place for eligible items bought during travel and bona fide gifts from foreign citizens to U.S. residents. The bill also establishes a civil penalty, starting 30 days after its enactment, for any person attempting to use de minimis entry in a way that "violates any other provision of" U.S. customs law. The amount is $5,000 for the first violation and up to $10,000 for subsequent violations. The move builds upon the Trump administration's efforts to restrict the de minimis exemption, which lawmakers and customs officials have scrutinized in recent years due to contraband entering the U.S. via low-cost packages. Earlier this year, the White House removed the exemption for imports from China and Hong Kong and announced its plans to end de minimis for other countries once systems are in place to collect duty revenue. The vast majority of de minimis volume entering the U.S. originated from China prior to the May 2 ban, making up 76% of shipments in Custom and Border Protection's 2024 fiscal year. The full repeal of the exemption in two years would expose low-cost shipments from Canada, Mexico and other countries to tariffs and other import taxes. E-commerce companies like Shein and Temu have historically benefited from the exemption, which allows them to ship products made internationally direct to U.S. consumers without facing added duties. Some experts say de minimis-reliant supply chains will shift to more traditional bulk shipping models or expanded U.S. fulfillment operations due to policy changes by the Trump administration. Recommended Reading De minimis' future: 4 questions shippers should consider Sign in to access your portfolio

Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas

Yahoo

timean hour ago

  • Yahoo

Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott's future dual glucose-ketone sensor in the US. The collaboration aims to enhance real-time decision-making support for individuals with diabetes. The iLet Bionic Pancreas received FDA clearance in May 2023 and is distinguished as the first and only AID system that autonomously makes 100% of insulin dosing decisions. This eliminates the need for carb counting or manual insulin correction calculations for users, though they still need to be 'carb aware.' The system currently supports Abbott's FreeStyle Libre 3 Plus continuous glucose monitoring sensor, and the new agreement deepens the ongoing partnership between Beta Bionics and Abbott. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The new dual sensor is currently under development and is built on the same form factor as Abbott's FreeStyle Libre 3 Plus and will continuously monitor both glucose and ketone levels. Ketone monitoring is a crucial advancement as it can help detect early signs of diabetic ketoacidosis, which is a serious complication of diabetes. Abbott's dual glucose-ketone sensor has received FDA breakthrough device designation. Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells health care products. Beta Bionics Inc. (NASDAQ:BBNX) is a commercial-stage medical device company. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Has Jon Jones already ended his retirement?
Has Jon Jones already ended his retirement?

Yahoo

timean hour ago

  • Yahoo

Has Jon Jones already ended his retirement?

This retirement decision by Jon Jones might be even shorter than his previous one. The former UFC heavyweight and light heavyweight champion claims he has re-entered into the drug testing policy. What has sparked this move by Jones? It would appear the recently announced UFC event that is expected to take place in Washington, D.C. from the White House in 2026. Advertisement "Fighting at the White House?" Jones posted on social media with an emoji of two wide-open eyes. MORE: President Donald Trump reveals UFC event at White House in 2026 He added "Just re-entered the testing pool, that lasted for about two weeks. Figured we'd keep everyone's options open." Jones, the heavyweight champion at the time, announced his retirement late last month. The promotion moved quickly to promote interim titleholder Tom Aspinall to the undisputed champion. President Donald Trump stated recently that he wants the UFC on the grounds of the White House for an event to celebrate America next year. Jones greeted Trump Octagon-side after defeating Stipe Miocic in his last match. Advertisement MORE UFC NEWS:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store